Voice your opinion on congressional bill S4338-117 and let lawmakers know your stance with UnPac!

Main Subject: Health

Increasing Transparency in Generic Drug Applications Act

This bill requires the Food and Drug Administration to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why).

HR7032-117, HR7667-117,

Senate Actions

IntroReferral
May. 26 2022	Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Library of Congress Actions

IntroReferral
May. 26 2022	Introduced in Senate

Senate bill S4338-117

Increasing Transparency in Generic Drug Applications Act

Promote the cause!

Or use this QR code